| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |